ASCENDIS PHARMA A/S - ADR (ASND) Institutional Ownership and Insiders Activity

ASCENDIS PHARMA A/S - ADR (ASND) is widely held by institutional investors, with 12 firms reporting positions valued at approximately $103.88M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Frazier Life Sciences Management, L.P. is the largest disclosed holder, reporting approximately $60.05M in ASND holdings in its latest filing.

Institutional ownership remains highly concentrated, with Frazier Life Sciences Management, L.P. representing the majority of disclosed value.

Recent insider activity includes 4 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.